Beilstein J. Org. Chem. 2011, 7, 631–637.
pounds with various other gold-catalyzed transformations. 7.64–7.62 (m, 1H), 7.39–7.35 (m, 1H), 7.30–7.19 (m, 4H),
Further studies to broaden the scope of these reactions are 7.11–7.09 (m, 1H), 6.27 (s, 1H), 5.87 (s, 1H), 3.76 (s, 3H);
currently underway.
13C NMR (100 MHz, CDCl3) δ 170.1, 151.5, 135.5, 133.5,
131.4, 130.1, 129.9, 129.1, 127.3, 127.2, 125.9, 125.5,
124.2, 106.0, 77.2, 52.5; MS (70 eV) m/z (%): 344 (41,
Experimental
General. For chromatography, 200–300 mesh silica gel 79Br) [M+], 285 (100), 206 (36), 178 (96), 151 (17);
(Qingdao, China) was employed. 1H NMR and 13C NMR HRMS–ESI (m/z): [M + H]+ calcd for C17H14BrO3, 345.0120;
spectra were recorded on Varian 300 or Bruker ARX 400 found, 345.0125.
spectrometer in CDCl3 solution and chemical shifts are reported
in parts per million (δ) relative to internal standard TMS (0 Methyl 3-(2-bromobenzylidene)-1,3-dihydroisobenzofuran-
ppm). Mass spectra were obtained on a VG ZAB-HS mass 1-carboxylate (3b). 1H NMR (400 MHz, CDCl3) δ 8.36–8.34
spectrometer. Diazo compounds were prepared according to our (m, 1H), 7.66 (d, J = 8.0 Hz, 1H), 7.58–7.52 (m, 2H), 7.41–7.39
previous reported procedures. Unless otherwise noted, materials (m, 2H), 7.34–7.29 (m, 1H), 7.03–7.01 (m, 1H), 6.42 (s, 1H),
obtained from commercial suppliers were used without further 6.05 (s, 1H), 3.82 (s, 3H); 13C NMR (100 MHz, CDCl3) δ
purification.
168.9, 155.9, 136.6, 134.9, 134.2, 132.6, 130.0, 129.5, 129.4,
127.3, 127.0, 123.0, 122.1, 96.1, 82.6, 52.8; MS (70 eV) m/z
General procedure for the gold(I)-catalyzed cascade inser- (%): 344 (13, 79Br) [M+], 285 (100), 206 (32), 178 (67), 151
tion/cyclization reaction. Distilled water (0.5 mL) was added (14); HRMS–ESI (m/z): [M + H]+ calcd for C17H14BrO3,
to a solution of complex 1 (0.5 mmol) and (IPr)AuCl (3 mol %, 345.0120; found, 345.0127.
9.3 mg) in DMF (1.5 mL) at room temperature under a N2
atmosphere. The reaction mixture was stirred for 24 h at 80 °C. Methyl 3-(3-bromophenyl)-1H-isochromene-1-carboxylate
After the mixture cooled to room temperature, it was diluted (2c). 1H NMR (400 MHz, CDCl3) δ 7.96–7.95 (m, 1H),
with ether and water. The aqueous phase was extracted with 7.72–7.71 (m, 1H), 7.49–7.47 (m, 1H), 7.32–7.25 (m, 4H),
Et2O (2 × 10 mL) and the combined organic extracts were 7.11–7.09 (m, 1H), 6.37 (s, 1H), 5.86 (s, 1H), 3.71 (s, 3H);
washed with brine (1 × 10 mL), dried over Na2SO4, and 13C NMR (100 MHz, CDCl3) δ 170.1, 151.3, 136.1, 131.8,
concentrated. Purification by column chromatography on silica 129.8, 129.1, 128.6, 127.1, 126.2, 125.7, 124.2, 124.1,
gel afforded products 2 and 3.
122.6, 101.4, 76.2, 52.6; MS (70 eV) m/z (%): 344 (34,
79Br) [M+], 285 (100), 206 (35), 178 (82), 151 (14);
Ethyl 3-phenyl-1H-isochromene-1-carboxylate (2a). HRMS–ESI (m/z): [M + H]+ calcd for C17H14BrO3, 345.0120;
1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 6.8 Hz, 2H), found, 345.0117.
7.41–7.35 (m, 3H), 7.28–7.20 (m, 3H), 7.09 (d, J = 7.6 Hz, 1H),
6.36 (s, 1H), 5.83 (s, 1H), 4.15 (m, 2H), 1.19 (t, J = 7.2 Hz, Methyl 3-(3-bromobenzylidene)-1,3-dihydroisobenzofuran-
3H); 13C NMR (100 MHz, CDCl3) δ 170.0, 153.0, 134.2, 130.6, 1-carboxylate (3c). 1H NMR (400 MHz, CDCl3) δ 7.94–7.93
129.18, 129.16, 128.4, 126.7, 126.2, 126.0, 125.8, 124.1, 100.5, (m, 1H), 7.68–7.66 (m, 1H), 7.55–7.52 (m, 2H), 7.45–7.38 (m,
76.6, 61.7, 14.2; MS (70 eV) m/z (%): 280 (29) [M+], 207 2H), 7.30–7.27 (m, 1H), 7.22–7.17 (m, 1H), 6.07 (s, 1H), 5.92
(100), 178 (47), 152 (8); HRMS–ESI (m/z): [M + H]+ calcd for (s, 1H), 3.82 (s, 3H); 13C NMR (100 MHz, CDCl3) δ 168.9,
C18H17O3, 281.1172; found, 281.1168.
155.7, 137.8, 136.8, 134.0, 130.8, 129.8, 129.47, 129.44, 128.5,
126.7, 122.5, 122.2, 120.1, 96.4, 82.6, 52.8; MS (70 eV) m/z
Ethyl 3-benzylidene-1,3-dihydroisobenzofuran-1-carboxy- (%): 344 (28, 79Br) [M+], 285 (100), 206 (34), 178 (50), 151
late (3a). 1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 7.2 Hz, (19); HRMS–ESI (m/z): [M + H]+ calcd for C17H14BrO3,
2H), 7.75–7.55 (m, 1H), 7.53–7.51 (m, 1H), 7.41–7.32 (m, 4H), 345.0120; found, 345.0126.
7.18–7.17 (m, 1H), 6.03 (s, 1H), 6.00 (s, 1H), 4.33–4.23 (m,
2H), 1.31 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ Methyl 3-p-tolyl-1H-isochromene-1-carboxylate (2d).
168.8, 154.8, 136.8, 135.8, 134.6, 129.4, 129.1, 128.5, 128.4, 1H NMR (400 MHz, CDCl3) δ 7.69 (d, J = 8.4 Hz, 2H),
125.9, 122.3, 120.1, 97.9, 82.6, 62.0, 14.3; MS (70 eV) m/z (%): 7.25–7.17 (m, 5H), 7.05 (d, J = 6.8 Hz, 1H), 6.31 (s, 1H), 5.83
280 (11) [M+], 264 (8), 207 (100), 191 (13), 178 (43); (s, 1H), 3.67 (s, 3H), 2.36 (s, 3H); 13C NMR (100 MHz,
HRMS–ESI (m/z): [M + H]+ calcd for C18H17O3, 281.1172; CDCl3) δ 170.4, 153.1, 139.2, 131.4, 130.7, 129.17, 129.15,
found, 281.1166.
126.5, 126.2, 125.76, 125.71, 123.9, 99.7, 76.5, 52.5, 21.4; MS
(70 eV) m/z (%): 280 (17) [M+], 221 (100), 207 (7), 178 (27);
Methyl 3-(2-bromophenyl)-1H-isochromene-1-carboxylate HRMS–ESI (m/z): [M + H]+ calcd for C18H17O3, 287.1172;
(2b). 1H NMR (400 MHz, CDCl3) δ 7.89–7.86 (m, 1H), found, 281.1168.
635